Trial
NCT04677179
A Study of LY3471851 in Adult Participants With Moderately to Severely Active Ulcerative Colitis (UC)
Phase IITERMINATEDEFFICACY/FUTILITYConfidence: HIGH
Sponsor
Nektar Therapeutics
Collaborators
Eli Lilly and Company
Condition
Colitis, Ulcerative
Intervention
LY3471851
Why stopped
Study terminated due to enrollment futility.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-09-05